Neuralink, Elon Musk’s brain-computer interface (BCI) startup, raised US$650M in its latest Series E funding round.

Blindsight: How it works and its ambitious goals Blindsight is Neuralink’s bold attempt to help people who have lost their vision regain some sense of sight, even for those who have lost both ...

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore ...

Neuralink is building a brain-computer interface, or BCI, which is a system that translates brain signals into commands for ...

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind patients regain their sight, the firm announced. Dubbed “Blindsight ...

Elon Musk recently pronounced that the next Neuralink project will be a “Blindsight” cortical implant to restore vision: “Resolution will be low at first, like early Nintendo graphics ...

The Tesla CEO said that Neuralink, another one of his tech companies, planned on implanting its new brain chip, Blindsight, into a human patient for the first time in late 2025. Newsweek contacted ...

As Neuralink continues its efforts to develop brain interface technology, one of its irons in the fire is Blindsight, which is a technology and procedure meant to provide eyesight back to those ...

Neuralink has proven its electronics to brain connection device and now has FDA approval for a Blindsight device. It would be a real life version of the Geordie Laforge’s visor in Star Trek the Next ...

Billionaire Elon Musk has shared a major Neuralink update at the Qatar Economic Forum with the Neurotechnology company's Brain-Chip Interface Blindsight set for its maiden trial next year.

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration (FDA) has granted 'breakthrough device' status to Neuralink's Blindsight, an experimental implant designed to restore vision.

With two separate “breakthrough” developments that are both poised to revolutionize the world of ophthalmology, the world could soon change for people who are visually impaired or even born blind.